Medina-Liabres Kristianne Rachel P, Jeong Jong Cheol, Oh Hyung Jung, An Jung Nam, Lee Jung Pyo, Kim Dong Ki, Ryu Dong-Ryeol, Kim Sejoong
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Ewha Institute of Convergence Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Kidney Res Clin Pract. 2021 Sep;40(3):401-410. doi: 10.23876/j.krcp.20.205. Epub 2021 Jul 5.
Because of high cost of continuous renal replacement therapy (CRRT) and the high mortality rate among severe acute kidney injury patients, careful identification of patients who will benefit from CRRT is warranted. This study determined factors associated with mortality among critically ill patients requiring CRRT.
This was a retrospective observational study of 414 patients admitted to the intensive care unit of four hospitals in South Korea who received CRRT from June 2017 to September 2018. Patients were divided according to degree of fluid overload (FO) and disease severity. The Cox proportional hazards model was used to explore the effect of relevant variables on mortality.
In-hospital mortality rate was 57.2%. Ninety-day mortality rate was 58.5%. Lower creatinine and blood pH were significant predictors of mortality. A one-unit increase in the Sequential Organ Failure Assessment (SOFA) score was associated with increased risk of and 90-day mortality (hazard ratio [HR], 1.07; p < 0.001). The risk of 90-day mortality in FO patients was 57.2% (p < 0.001) higher than in those without FO. High SOFA score was associated with increased risk for 90-day mortality (HR, 1.79; p = 0.03 and HR, 3.05; p = 0.001) in patients without FO and with FO ≤ 10%, respectively. The highest mortality rates were in patients with FO > 10%, independent of disease severity.
FO increases the risk of mortality independent of other factors, including severity of acute illness. Prevention of FO should be a priority, especially when managing the critically ill.
由于持续肾脏替代治疗(CRRT)成本高昂,且重症急性肾损伤患者死亡率高,因此有必要仔细甄别能从CRRT中获益的患者。本研究确定了需要CRRT的危重症患者的死亡相关因素。
这是一项回顾性观察研究,研究对象为2017年6月至2018年9月在韩国四家医院重症监护病房接受CRRT的414例患者。根据液体超负荷(FO)程度和疾病严重程度对患者进行分组。采用Cox比例风险模型探讨相关变量对死亡率的影响。
住院死亡率为57.2%。90天死亡率为58.5%。较低的肌酐水平和血液pH值是死亡率的重要预测指标。序贯器官衰竭评估(SOFA)评分每增加1个单位,住院死亡率和90天死亡率风险增加(风险比[HR],1.07;p<0.001)。FO患者90天死亡风险比无FO患者高57.2%(p<0.001)。在无FO和FO≤10%的患者中,高SOFA评分分别与90天死亡风险增加相关(HR,1.79;p=0.03和HR,3.05;p=0.001)。无论疾病严重程度如何,FO>10%的患者死亡率最高。
FO会增加死亡风险,且独立于其他因素,包括急性疾病严重程度。预防FO应成为首要任务,尤其是在治疗危重症患者时。